Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-05-18

Clinical Trial Update: Comparison of Voice Therapy and Antireflex Therapy in LPR [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Voice Therapy and Antireflux Therapy for Laryngopharyngeal Reflux has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Temple University | Conditions: Laryngopharyngeal Reflux | Phase 4 | Status: WITHDRAWN